Income Taxes (Tables)

12 Months Ended

Dec. 31, 2021

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

The domestic and foreign components of loss before income taxes for the years ended December 31, 2021 and 2020 are as follows (in thousands):

	For the Years Ended December 31,
	2021		2020
Domestic	$	(58,960)	$	(24,387)
Foreign	(12,582)		(4,883)
Loss from Continuing Operations before Provision for Income Taxes	$	(71,542)	$	(29,270)

Schedule of Components of Income Tax Expense (Benefit)

The income tax provision (benefit) for the years ended December 31, 2021 and 2020 consists of the following (in thousands):

	For the Years Ended December 31,
	2021		2020
Foreign
Current	$	33	$	31
Deferred	2,376		(1,815)
U.S. federal
Current	929		—
Deferred	(9,345)		(5,367)
State and local
Current	217		3
Deferred	(66)		(1,181)
	(5,856)		(8,329)
Change in valuation allowance	4,444		8,273
Income Tax Benefit	$	(1,412)	$	(56)

Schedule of Effective Income Tax Rate Reconciliation

The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective rate for the years ended December 31, 2021 and 2020 is as follows:

	For the Years Ended December 31,
	2021		2020
U.S. federal statutory rate	21.0	%	21.0	%
State income taxes, net of federal benefit	(0.17)	%	3.2	%
Incentive stock options	(0.18)	%	(0.4)	%
162(m) Compensation Limit	(0.47)	%	—	%
Goodwill impairment loss	(4.76)	%	—	%
US-Foreign income tax rate difference	1.20	%	1.0	%
Other permanent items	(0.32)	%	—	%
Provision to return adjustments	(1.66)	%	(0.8)	%
Deferred only adjustment	(6.46)	%	4.5	%
Change in valuation allowance	(6.21)	%	(28.3)	%
Effective Rate	1.97	%	0.2	%

Schedule of Deferred Tax Assets and Liabilities

As of December 31, 2021 and 2020, the Company’s deferred tax assets consisted of the effects of temporary differences attributable to the following:

	As of December 31,
(in 000s)	2021		2020
Deferred Tax Asset
Net operating loss carryovers	$	35,033	$	30,731
Stock based compensation	2,540		1,253
Research credits	131		138
Accrued compensation	96		86
Reserves	345		151
Intangibles	—		7,411
Fixed assets	393		471
Unrealized gain	12,876		—
Other	260		3,349
Total Deferred Tax Asset	51,674		43,590
Less: valuation allowance	(46,071)		(38,287)
Deferred Tax Asset, Net of Valuation Allowance	$	5,603	$	5,303

	As of December 31,
Deferred Tax Liabilities	2021		2020
Intangible assets	$	(4,613)	$	(4,362)
Fixed assets	(239)		(135)
Other	(381)		(440)
Capitalized research	(370)		(366)
Total deferred tax liabilities	(5,603)		(5,303)
Net Deferred Tax Asset (Liability)	$	—	$	—